Safety and Efficacy of Integrative Korean Medicine Treatment for Elderly After Traffic Accident: Retrospective Chart Review Study
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 1,788
- 试验地点
- 4
- 主要终点
- Numeric Rating Scale (NRS)
研究概览
简要总结
The purpose of this study was to analyze the medical records of elderly traffic accident patients hospitalized at 4 branches of Jaseng Korean Medicine Hospital to determine the status of elderly patients and the effectiveness and safety of Korean medicine combination treatment.
详细描述
This study was retrospective chart review study and was conducted in 4 branches of Jaseng Korean Medicine Hospital (Gangnam, Bucheon, Daejeon, Haeundae).
研究设计
- 研究类型
- Observational
- 观察模型
- Other
- 时间视角
- Retrospective
入排标准
- 年龄范围
- 65 Years 至 —(Older Adult)
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Patients aged 65 years or older at the time of first visit
- •Patients who visited our hospital due to symptoms caused by a traffic accident and received integrated oriental medicine treatment at least once as an inpatient treatment
排除标准
- •If only consultation was conducted at the hospital or only Western medicine treatment was conducted
- •If only outpatient treatment was received without hospitalization
- •If other researcher judges that participation in the study is difficult
结局指标
主要结局
Numeric Rating Scale (NRS)
时间窗: The results are measured for each patient at admission (before) and discharge (after) from January 2021 to December 31, 2023.
NRS uses an 11-point scale to evaluate current main pain and radiating pain where no pain is indicated by '0', and the worst pain imaginable by '10'.
次要结局
- euroqol-5 dimension (EQ-5D)(The results are measured for each patient at admission (before) and discharge (after) from January 2021 to December 31, 2023.)
- Neck Disability Index (NDI)(The results are measured for each patient at admission (before) and discharge (after) from January 2021 to December 31, 2023.)
- Oswestry Disability Index (ODI)(The results are measured for each patient at admission (before) and discharge (after) from January 2021 to December 31, 2023.)
- Adverse Events (AE)(The period of hospitalization is limited to January 2021 to December 2023.)
